Artificial Pancreas: A Dialogue between the FDA and the Diabetes Community - June 2, 2016
Meeting Materials
Presentation 
Note: this file is audio only and contains no video.- Transcript (PDF - 298KB)
A Dialogue about the Artificial Pancreas between the Diabetes Community and FDA.
On Thursday, June 2, 2016, the FDA hosted a webinar to share general information about how the FDA regulates diabetes devices and ongoing efforts to accelerate the availability of artificial pancreas devices. The webinar focused on current and emerging artificial pancreas technologies, and the FDA’s role in reviewing these technologies for safety and effectiveness. Representatives from the FDA and the Diabetes Patient Advocacy Coalition were available to answer questions from webinar participants.
Target Audience: Diabetes Patient Groups
If you have any general questions about the FDA’s regulation of medical devices, please contact CDRH’s Division of Industry and Consumer Education (DICE) at dice@fda.hhs.gov, 1-800-638-2041, or 301-796-7100.
Food and Drug Administration
Center for Devices and Radiological Health